Stock under Discussion: Valeant Pharmaceuticals International, Inc. (VRX)

Share

(NYSE:VRX)'s earnings per share has been growing at a 61.43 percent rate over the past 5 year when average revenue increase was noted as 31.9 percent. It operates through two segments: Developed markets and Emerging markets. Moreover, Boothbay Fund Mgmt Llc has 0.11% invested in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) for 29,612 shares. Valeant Pharmaceuticals International had a positive return on equity of 59.89% and a negative net margin of 12.40%. Valeant Pharmaceuticals Intl now has $5.02B valuation. It is 0.00% or $0 reaching $0.71 per share.

Now we will discuss the financial strength of Valeant Pharmaceuticals International, Inc. It has underperformed by 16.70% the S&P500. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data.

When it comes to the Analysis of a Stock, Price Target plays a vital role. GNC was included in 5 notes of analysts from September 23, 2016. Goldman Sachs initiated the stock with "Sell" rating in Tuesday, December 15 report. As per Friday, May 20, the company rating was upgraded by Citigroup. (VRX) will report its next earnings on Nov 07 BMO. SYY's profit will be $381.64 million for 18.48 P/E if the $0.73 EPS becomes a reality.

Investors wait Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to report on November, 14. its quarterly earnings Wall Street analysts expect $0.96 EPS, down $0.59 or 38.06 % from last year's $1.55 same quarter earnings.

Since May 11, 2017, it had 1 insider purchase, and 0 selling transactions for $278,000 activity. The Continental Advisors Llc holds 93,200 shares with $1.61 million value, up from 71,000 last quarter.

Cove Street Capital Llc holds 4.32% of its portfolio in Heritage-Crystal Clean, Inc. for 2.24 million shares. OLD Mutual Customised Solutions Proprietary Ltd. now owns 11,900 shares of the specialty pharmaceutical company's stock valued at $131,000 after acquiring an additional 9,300 shares during the period. Glenmede Na owns 0.54% invested in SYSCO Corporation (NYSE:SYY) for 2.19 million shares. Point72 Asset Management Lp, Connecticut-based fund reported 50,000 shares. On a Monthly basis the stock is 7.62%.

First Republic Investment Management Inc decreased Unitedhealth Group Inc (NYSE:UNH) stake by 41,509 shares to 360,202 valued at $66.79M in 2017Q2. It has underperformed by 87.39% the S&P500.

Among 27 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 3 Sell and 18 Hold. Therefore 33% are positive. Zacks Investment Research cut Valeant Pharmaceuticals International from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 13th. RBC Capital Markets maintained it with "Sector Perform" rating and $39 target in Monday, November 28 report. According to these analysts, the Low Revenue Estimate for Valeant Pharmaceuticals International, Inc.is 270.8 Million and the High Revenue Estimate is 333 Million. RBC Capital Markets has "Outperform" rating and $213 target. Deutsche Bank maintained the shares of LOW in report on Thursday, August 24 with "Buy" rating.

07/06/2017 - Valeant Pharmaceuticals International, Inc. had its "neutral" rating reiterated by analysts at JP Morgan. The stock of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has "Hold" rating given on Friday, August 4 by Canaccord Genuity. They now have a Dollars 20 price target on the stock. Morgan Stanley maintained Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Tuesday, November 17 with "Equal-Weight" rating. The company has a consensus rating of "Hold" and a consensus target price of $17.73. On Thursday, November 10 the stock rating was downgraded by Rodman & Renshaw to "Neutral".

Short interest decreased 1,816,075 over that timeframe.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. The funds in our partner's database now hold: 171.89 million shares, up from 169.40 million shares in 2017Q1. Comparatively, Valeant Pharmaceuticals International, Inc. posted earnings of $2.12 per share in the same quarter past year. City Hldgs holds 270 shares or 0% of its portfolio. There has been an observed change of 0.37% in the ownership of the shares in the past six months. The Korea-based Korea has invested 0% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Phoenix Adviser Limited Liability has 175,000 shares. Andra Ap accumulated 73,200 shares. Architects holds 0.03% or 10,550 shares. The rating was maintained by Jefferies with "Buy" on Wednesday, March 16. Great West Life Assurance Can holds 0.01% or 253,889 shares in its portfolio. Susquehanna Intll Group Inc Ltd Liability Partnership reported 5.19 million shares.

News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International, Inc. with MarketBeat.com's FREE daily email newsletter.

Share